Julie Derving Karsbøl, MD

Senior International Medical Director
Novo Nordisk, Hovedstaden, Denmark

Disclosure information not submitted.

Presentation(s):

• ASCENT1: A Phase 2 Trial to Evaluate the Efficacy and Safety of Oral Decitabine–Tetrahydrouridine (NDec) in Patients with Sickle Cell Disease

  Sunday, June 18, 2023
  3:30 PM – 3:45 PM East Coast USA Time